Arpraziquantel

Anthelmintic medication

Arpraziquantel
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Arpraziquantel is an anthelmintic medication used primarily for the treatment of schistosomiasis, a disease caused by parasitic flatworms known as schistosomes. It is a derivative of praziquantel, specifically the R-enantiomer, which has been found to be more effective and better tolerated in certain populations.

Pharmacology

Arpraziquantel works by causing severe spasms and paralysis of the worms' muscles. This action is believed to be due to an increase in the permeability of the cell membranes to calcium ions, leading to the contraction and eventual death of the parasite. The drug is particularly effective against the adult stages of the parasite.

Medical Uses

Arpraziquantel is primarily used to treat infections caused by various species of schistosomes, including Schistosoma mansoni, Schistosoma haematobium, and Schistosoma japonicum. It is also effective against other trematode infections and some cestode infections.

Dosage and Administration

The dosage of arpraziquantel is typically determined based on the type of infection and the patient's body weight. It is usually administered orally, and the treatment regimen may vary depending on the specific schistosome species involved.

Side Effects

Common side effects of arpraziquantel include dizziness, headache, nausea, and abdominal pain. These side effects are generally mild and transient. In some cases, more severe reactions such as allergic responses or cardiac arrhythmias may occur.

Development and Approval

Arpraziquantel was developed as a more effective and better-tolerated alternative to racemic praziquantel. It has undergone various clinical trials to establish its efficacy and safety profile, particularly in pediatric populations where schistosomiasis is prevalent.

Mechanism of Action

Structural formula of (R)-Praziquantel

The mechanism of action of arpraziquantel involves the disruption of calcium ion homeostasis in the parasite, leading to tetanic contraction and paralysis. This effect is more pronounced in the R-enantiomer compared to the S-enantiomer, which is why arpraziquantel is preferred in certain cases.

Related Pages

• Praziquantel
• Schistosomiasis
• Anthelmintic
• Trematode
• Cestode